MAZ51 is primarily utilized in research settings to study cellular processes and signaling pathways. It is known for its role as an inhibitor of VEGFR (Vascular Endothelial Growth Factor Receptor), which makes it valuable in investigating angiogenesis, the formation of new blood vessels. Researchers use MAZ51 to explore its effects on tumor growth and metastasis, as inhibiting angiogenesis can potentially restrict the blood supply to cancerous tissues. Additionally, it is employed in studies related to endothelial cell behavior and vascular development. Its application extends to understanding diseases where abnormal blood vessel formation plays a critical role, such as cancer, diabetic retinopathy, and other vascular disorders.